Biomarkers for Sjögren's syndrome

Area of Science:

• Immunology
• Rheumatology
• Biomarker Discovery

Background:

• Primary Sjögren's syndrome (pSS) is a heterogeneous autoimmune disorder with unmet diagnostic and prognostic needs.
• Current diagnostic and prognostic tools for pSS have limitations in clinical practice.

Purpose of the Study:

• To review established clinical, serological, and histological biomarkers for pSS.
• To explore emerging novel biomarkers for improved pSS assessment.

Main Methods:

• Comprehensive literature review of existing and novel biomarkers for primary Sjögren's syndrome.
• Analysis of the relevance and limitations of traditional biomarkers.
• Exploration of potential new biomarkers in recent scientific literature.

Main Results:

• Traditional biomarkers (clinical, serological, histological) are widely used but have limitations.
• Novel biomarkers show promise for enhancing diagnostic accuracy and prognostic stratification in pSS.
• Further research is needed to validate and integrate new biomarkers into clinical practice.

Conclusions:

• Biomarkers are crucial for advancing the diagnosis and management of primary Sjögren's syndrome.
• A combination of traditional and novel biomarkers may offer a more comprehensive approach to pSS assessment.
• Continued investigation into biomarker utility is essential to address the unmet needs in pSS.